首页> 外文期刊>Basic & clinical pharmacology & toxicology. >Down-regulation of CD40 gene expression and inhibition of apoptosis with Danshensu in endothelial cells.
【24h】

Down-regulation of CD40 gene expression and inhibition of apoptosis with Danshensu in endothelial cells.

机译:丹参素对内皮细胞CD40基因表达的下调和对细胞凋亡的抑制作用。

获取原文
获取原文并翻译 | 示例
       

摘要

Danshen is commonly used in China for the treatment of atherosclerosis-related disorders such as cardiovascular and cerebrovascular diseases. Research shows that it also has immunostimulation properties. The present study evaluates the protective effect of danshensu, an active water-extractable component isolated from danshen, on an endothelial cell line (CRL-1730) treated with hydrogen peroxide (H(2)O(2)). Danshensu significantly inhibited endothelial cell viability induced by H(2)O(2). The treatment of endothelial cells with danshensu resulted in most cells being arrested in the S and G(2)/M phases of the cell cycle. The fraction of cells in G(0)/G(1) phase was markedly decreased by danshensu treatment compared to the control groups. The apoptosis was also markedly decreased after danshensu treatment. Additionally, danshensu restrains decreased nitric oxide level, increased the release of lactate dehydrogenase and expression of cluster of differentiation 40 (CD40) significantly. These results suggestthat danshensu protects endothelial cells from the damage induced by H(2)O(2) through its CD40 anti-inflammatory approach and cell apoptosis inhibition.
机译:丹参在中国通常用于治疗与动脉粥样硬化相关的疾病,例如心血管和脑血管疾病。研究表明,它还具有免疫刺激特性。本研究评估了丹参素(一种从丹参中分离出的活性水提取成分)对用过氧化氢(H(2)O(2))处理的内皮细胞系(CRL-1730)的保护作用。丹参素显着抑制H(2)O(2)诱导的内皮细胞活力。用丹参素治疗内皮细胞导致大多数细胞在细胞周期的S和G(2)/ M期停滞。与对照组相比,丹参素处理显着降低了G(0)/ G(1)相中的细胞分数。丹参素治疗后细胞凋亡也明显减少。此外,丹参素可显着抑制一氧化氮水平的降低,乳酸脱氢酶的释放和分化簇40(CD40)的表达。这些结果表明,丹参素通过其CD40抗炎方法和细胞凋亡抑制作用,保护内皮细胞免受H(2)O(2)诱导的损害。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号